Best Biopharma Outsourcing Companies in Beijing, China
The 44 best Biopharma Outsourcing companies in Beijing, China in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Pharmaron.
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Beijing
| # | Company | Last round | Disclosed funding | Employees | Founder | Stage | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Beijing Ruicheng Haihui Health Technology Developer of plant bioreactor technology based products | — | — | — | Kevin Yueju Wang Founder | Deadpooled | — | — |
| 2 | Beijing Shuanglu Pharmaceutical Manufacturer of generic formulations | — | — | 757 | Mingbo Xu Founder & CEO | Public | — | — |
| 3 | Beijing THTD pharmaceutical technology Manufacturer of APIs and pharmaceutical intermediates | — | — | — | Hongpin Wang CEO | Deadpooled | — | — |
| 4 | Beijing Xinda Ark Technology Development CMO engaged in the manufacture of APIs and pharma intermediates | — | — | — | Tian CEO | Unfunded | — | — |
| 5 | Beijing Yaxincheng Medical Information Technology Provider of marketing, management, training and medical interpretation services | — | — | 200 | — | Funding Raised | — | — |
| 6 | Beijing Zhongshuo Pharmaceutical Technology Manufacturer of APIs & pharmaceutical intermediates | — | — | — | — | Unfunded | — | — |
| 7 | CRO Provider of clinical trial management, market research and regulatory services | — | — | — | Liu Yanan CEO | Funding Raised | — | — |
| 8 | Gnovo Healthcare company that develops and commercializes innovative treatments for serious chronic diseases | — | — | 296 | — | Unfunded | — | — |
Top 12 Biopharma Outsourcing companies in Beijing
#1
Series C · Beijing, Beijing · founded 2010 · 19 employees$14Mraised▾
ICE Bioscience is a specialised preclinical CRO offering ion channel based screening services through their expertise in electrophysiology. They offer a range of services for cardiac safety screening (hERG screening, QT-prolongation etc.), ion channel profiling (Voltage-gated, ion-gated, and other channels (CRAC and chloride channels)) and in-vitro high-throughput screening (GPCR and Protein Kinase assays, cell line generation etc.)
- May 2024Series C—
- Sep 2022Series B$14M
#2
Series A · Changping District, Beijing · founded 2016$26.5Mraised▾
Biotechnology company focused on developing gene therapy drugs for eye diseases. It is a high-tech enterprise focusing on gene therapy drug development and genetic diagnosis for inherited eye diseases.
- Oct 2023Series A—
- Mar 2022Series A$15.7M
- Mar 2021Seed$10.7M
#3
Public · Beijing, Beijing · founded 2003 · 476 employees$320Mraised▾
Pharmaron offers a suite of drug discovery and development services for small molecules, nucleosides, nucleotides, peptides, lipids and carbohydrates. They offer their R&D services across a number of disciplines including chemistry, biology, DMPK, pharmacology, toxicology and chemical and formulation development. The company claims that their chemistry division is one of the largest chemistry service providers in the world with experience and expertise in organic synthesis, library/high-throughput synthesis, chiral chemistry, medicinal, computational and cheminformatics, bioorganic chemistry, process and scale-up, analytical and purification. Their biologics division offers services such as antibody/protein engineering, antibody humanization, cell line development, recombinant antibody production, protein expression, purification, and characterization.The company has acquired Xceleron and SNBL CPC to augment its offerings.
- Dec 2015PE$280M
- Mar 2011Series C$40M
- Sep 2009Grant (prize money)$818.3K
- Sep 2009Grant (prize money)$818.3K
#4
Public · Beijing, Beijing · founded 2002 · 148 employees$135.2Mraised▾
Beijing Biostar Technologies develops and manufactures APIs, intermediates, and biochemical reagents. The company offers development services including biomedical development, technology and transfer of anti-tumor small molecules, and technical service consulting.
- Nov 2020Series E$135.2M
- Jan 2019Series B—
#5
Public · Beijing, Beijing · founded 1996 · 893 employees$100Mraised▾
Concord Medical Services operates a network of radiotherapy and diagnostic imaging centers in China. The Company operates a network of more than 141 centers with 81 hospitals spanning more than 56 cities in China. It uses advanced radiotherapy and diagnostic imaging equipment, such as linear accelerators, head gamma knife systems, body gamma knife systems, positron emission tomography-computed tomography (PET-CT) scanners or magnetic resonance imaging (MRI) scanners. The company also operates Cancer Hospitals in multiple cities like Beijing, Shanghai & Guangzhou.
- Mar 2020Post IPO$100M
- Oct 2017Post IPO—
- 2017Unattributed—
#6
Deadpooled · Haidian, Beijing · founded 2015$49.4Mraised▾
Provider of research and cell & gene therapy development services
#7
Series D · Beijing, Beijing · founded 2007 · 1000 employees$52.6Mraised▾
Bellen Chemistry is engaged in the design and development of novel molecules and intermediates for the chemical and pharmaceutical industries. The company has a product catalogue that includes over 10000+ heterocycles. The company's services include process research, manufacturing, custom synthesis, route scouting, medicinal chemistry, and process development. Their med chem services include preclinical candidate selection, intermediate, reference compound and impurity synthesis and asymmetric synthesis
- Jun 2020Series D—
- Sep 2018Series C$14.6M
- Sep 2017Series B$38M
#8
Series A · Changping District, Beijing · founded 2017$23.3Mraised▾
Developer and manufacturer of molecular diagnostic and reagent products. The company's products help researchers perform more successful DNA extractions, PCR/qPCR processes and other molecular processes.
- Feb 2021Series A$23.3M
#9
Series A · Beijing, Beijing · founded 2013 · 310 employees$23Mraised▾
Beijing Nokangda Pharmaceutical Technology is a provider of preclinical, clinical drug development and drug delivery services. The company offers pre-clinical research and development, clinical research, pilot production, scale-up, and post-marketing re-evaluation services. Also offers product development and manufacturing platform for drug delivery of medicines. Facilities are certified by ISO9001, OHSAS18001, and CNAS.
- Feb 2017Series A$23M
#10
Series B · Beijing, Beijing · founded 2005$15Mraised▾
Laviana Pharma is a contract development services provider. Its service offerings include process research, process development, custom synthesis, pilot manufacturing, commercial manufacturing, analytical services, impurity identification, CMC services etc. The company offers its services to pharmaceutical companies worldwide.
- Aug 2019Series B—
- Jan 2018Series B$15M
#11
Series C · Changping District, Beijing · founded 2016 · 200 employees—raised▾
Developer of a pharmaceutical industrialization innovation platform intended for small molecular and ADC (Antibody-Drug-Conjugates). The company has a well-trained and experienced drug research and development team, and it has a variety of advanced experimental equipment to support pre-clinical pharmacy research, providing domestic and foreign pharmaceutical companies with integrated pharmaceutical R&D services.
- Feb 2026Series C—
#12
Series C · Beijing, Beijing · founded 2015 · 500 employees—raised▾
CDMO focused on providing services for cell therapy and AAV vector products
- Sep 2022Series C—
- Sep 2021Series B—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Beijing is moving
A read on the academic research around Biotechnology in Beijing — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 276 papers.
- Beijing Academy of Agricultural and Forestry Sciences31
- Beijing Technology and Business University30
- Beijing Forestry University19
- Beijing University of Chemical Technology18
- Beijing University of Agriculture16
- Transcription factor1→7
- Transcriptome1→5
- Cleavage (geology)1→3
- Mutant1→3
- Transcription (linguistics)1→3
- Metabolomics8
- Agriculture7
- Fermentation6
- Gene5
- Production (economics)5
- Key (lock)4
- Food safety3
- Agriculture3
- Human health3
- Drug development3
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.